Safety and Efficacy of Fedratinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Primary Analysis of FREEDOM Trial
LEUKEMIA & LYMPHOMA（2024）
Key words
Fedratinib,myelofibrosis,spleen response,adverse events,gastrointestinal mitigation strategies,myelofibrosis symptom assessment form (MSAF)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined